We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+4.66%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$968M
AUM Growth
+$854M
Cap. Flow
+$792M
Cap. Flow %
81.87%
Top 10 Hldgs %
57.56%
Holding
371
New
110
Increased
49
Reduced
126
Closed
30

Top Buys

Rank Stock Value
1
EQM
EQM Midstream Partners, LP
EQM
+$80.7M
2
ETP
Energy Transfer Partners, L.P.
ETP
+$75.4M
3
MPLX icon
MPLX
MPLX
+$75.1M
4
MPC icon
Marathon Petroleum
MPC
+$60.6M
5
WMB icon
Williams Companies
WMB
+$40.5M

Top Sells

Rank Stock Value
1
VPU
Vanguard Utilities ETF
VPU
+$1.7M
2
VDE icon
Vanguard Energy ETF
VDE
+$1.28M
3
INDA icon
iShares MSCI India ETF
INDA
+$1.24M
4
FNCL icon
Fidelity MSCI Financials Index ETF
FNCL
+$1.04M
5
INCY icon
Incyte
INCY
+$637K

Sector Composition

Rank Sector Weight
1 Energy 68.15%
2 Healthcare 6.98%
3 Utilities 1.17%
4 Financials 0.09%
5 Technology 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FNCL icon
151
Fidelity MSCI Financials Index ETF
FNCL
$2.37B
$425K 0.04%
10,529
-25,398
-71% -$1.04M
SYRS
152
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$424K 0.04%
3,560
-2,612
-42% -$303K
CBIO
153
Crescent Biopharma
CBIO
$626M
$415K 0.04%
288
-206
-42% -$312K
VYGR icon
154
Voyager Therapeutics
VYGR
$187M
$414K 0.04%
21,869
-15,633
-42% -$300K
PRTK
155
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$413K 0.04%
42,584
-31,186
-42% -$315K
ATNX
156
DELISTED
Athenex, Inc. Common Stock
ATNX
$411K 0.04%
1,321
-945
-42% -$332K
PRTA icon
157
Prothena Corp
PRTA
$455M
$410K 0.04%
31,339
-23,019
-42% -$332K
RYTM icon
158
Rhythm Pharmaceuticals
RYTM
$7.28B
$410K 0.04%
14,044
-10,330
-42% -$326K
IMMU
159
DELISTED
Immunomedics Inc
IMMU
$410K 0.04%
19,666
-14,095
-42% -$334K
IOVA icon
160
Iovance Biotherapeutics
IOVA
$2.19B
$406K 0.04%
36,120
-25,831
-42% -$367K
SAGE
161
DELISTED
Sage Therapeutics
SAGE
$406K 0.04%
2,871
-2,052
-42% -$317K
RCUS icon
162
Arcus Biosciences
RCUS
$3.5B
$400K 0.04%
28,669
-21,065
-42% -$269K
CBAY
163
DELISTED
Cymabay Therapeutics
CBAY
$400K 0.04%
36,120
-25,831
-42% -$321K
HEP
164
DELISTED
Holly Energy Partners, L.P.
HEP
$400K 0.04%
+12,709
New +$387K
ARRY
165
DELISTED
Array Biopharma Inc
ARRY
$400K 0.04%
26,284
-18,803
-42% -$288K
PNW icon
166
Pinnacle West Capital
PNW
$12.8B
$388K 0.04%
+4,896
New +$393K
ALNY icon
167
Alnylam Pharmaceuticals
ALNY
$37.2B
$387K 0.04%
4,427
-3,154
-42% -$317K
GBT
168
DELISTED
Global Blood Therapeutics, Inc.
GBT
$382K 0.04%
10,053
-7,196
-42% -$319K
ABEO icon
169
Abeona Therapeutics
ABEO
$349M
$381K 0.04%
1,191
-851
-42% -$302K
PPL
170
PPL Corp
PPL
$27.1B
$380K 0.04%
+13,000
New +$380K
FPRX
171
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$373K 0.04%
26,824
-19,183
-42% -$285K
APLS
172
DELISTED
Apellis Pharmaceuticals
APLS
$372K 0.04%
20,895
-15,328
-42% -$283K
AKBA icon
173
Akebia Therapeutics
AKBA
$343M
$371K 0.04%
42,037
-30,371
-42% -$272K
SWX icon
174
Southwest Gas
SWX
$6.66B
$370K 0.04%
+4,680
New +$370K
AGEN
175
Agenus
AGEN
$255M
$360K 0.04%
8,560
-6,156
-42% -$242K
5 6
7
8 9

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q3 2018 Portfolio in Review

As of Q3 2018, Virtus ETF Advisers held 371 positions worth $968M, up 755% from $113M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Virtus ETF Advisers deployed $792M of net new capital in Q3 2018, opening 110 new positions and adding to 49 existing holdings. Its largest new stake was EQM Midstream Partners, LP: 1,479,454 shares worth $78.1M.

By sector, the portfolio is most concentrated in Energy at 68% of assets, up from 0.33% a quarter earlier, followed by Healthcare and Utilities.

On the sell side, the largest reduction was Vanguard Utilities ETF, an estimated $1.7M trimmed.

  • Virtus ETF Advisers's largest Q3 2018 buy was EQM Midstream Partners, LP: 1,479,454 shares worth $78.1M.
  • Virtus ETF Advisers added most to Marathon Petroleum in Q3 2018, an estimated $60.6M increase.
  • Virtus ETF Advisers's biggest Q3 2018 reduction was Vanguard Utilities ETF, cutting an estimated $1.7M.
  • Virtus ETF Advisers fully exited iShares MSCI India ETF in Q3 2018, selling an estimated $1.24M.
  • Virtus ETF Advisers's ten largest holdings make up 58% of its $968M portfolio in Q3 2018.
  • Virtus ETF Advisers opened 110 new positions and closed 30 in Q3 2018.
  • Virtus ETF Advisers's portfolio value rose 755% quarter-over-quarter to $968M.

Based on Virtus ETF Advisers's 13F filing for Q3 2018, filed 14 Nov 2018.